SOFIVA GENOMICS Co (ROCO:6615) PEG Ratio: N/A (As of Jul. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6615 SOFIVA GENOMICS Co Ltd ROCO:6615
68 GF Score
Price NT$34.05
GF Value NT$30.94
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is SOFIVA GENOMICS Co PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, SOFIVA GENOMICS Co's PE Ratio without NRI is 0.00. SOFIVA GENOMICS Co's 5-Year EBITDA growth rate is -17.70%. Therefore, SOFIVA GENOMICS Co's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for SOFIVA GENOMICS Co's PEG Ratio or its related term are showing as below:


During the past 13 years, SOFIVA GENOMICS Co's highest PEG Ratio was 37.67. The lowest was 2.55. And the median was 4.24.


ROCO:6615's PEG Ratio is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.305
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


SOFIVA GENOMICS Co  (ROCO:6615) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


SOFIVA GENOMICS Co PEG Ratio Related Terms


SOFIVA GENOMICS Co PEG Ratio Historical Data

* Premium members only.

The historical data trend for SOFIVA GENOMICS Co's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SOFIVA GENOMICS Co PEG Ratio Chart

SOFIVA GENOMICS Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.20 3.99 0.00 0.00 0.00

SOFIVA GENOMICS Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ROCO:6615 vs TMO, DHR, IDXX: PEG Ratio Comparison

For the Diagnostics & Research subindustry, SOFIVA GENOMICS Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SOFIVA GENOMICS Co PEG Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SOFIVA GENOMICS Co's PEG Ratio distribution charts can be found below:

* The bar in red indicates where SOFIVA GENOMICS Co's PEG Ratio falls into.


ROCO:6615
68GF Score
SOFIVA GENOMICS Co Ltd ROCO:6615
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SOFIVA GENOMICS Co PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

SOFIVA GENOMICS Co's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/-17.70
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Is SOFIVA GENOMICS Co (ROCO:6615) Overvalued in 2026?

Based on GuruFocus' analysis, SOFIVA GENOMICS Co stock appears to be overvalued. The current stock price of NT$34.05 is trading 10.1% above its estimated GF Value™ of NT$30.94. GuruFocus considers SOFIVA GENOMICS Co to be Fairly Valued.

Key valuation signals for ROCO:6615:

  • PEG Ratio: N/A
  • GF Value™: NT$30.94 vs. price of NT$34.05 (10.1% above fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the ROCO:6615 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SOFIVA GENOMICS Co Business Description

Address No. 66-1, Section 1, Chongqing S. Road, 4th Floor, Zhongzheng District, Taipei, TWN, 10043
SOFIVA GENOMICS Co Ltd provides medical diagnostic services. The services offered by the company include Prenatal, Reproductive, Cancer, Precision Medicine, Newborn, and Rare Diseases. Its testing categories include Genetic, Biochemical, and Chromosome. The business items of Sofiva Group are pre-pregnancy, prenatal, and neonatal genetic testing and medical testing, and other service income. Geographically, it generates the vast majority of its revenue from Taiwan.
68GF Score

Get the complete analysis for ROCO:6615

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$34.05
Price
NT$30.94
GF Value